Clinical Trials for Adjuvant Immunotherapy

Find clinical trials for adjuvant immunotherapy. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)

NCT ID: NCT07120698

This clinical trial is studying a treatment called sintilimab, which is an immunotherapy drug, for people with a specific type of lung cancer called non-small cell lung cancer (NSCLC), at stages II...

Not yet recruiting

Phase: PHASE2 Type: interventional

A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC

NCT ID: NCT06977828

This clinical trial is investigating a new treatment approach for patients with a type of lung cancer called non-small cell lung cancer (NSCLC) that is in a resectable stage (meaning it can be surg...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Nanjing, Jiangsu, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions